UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025745
Receipt number R000029588
Scientific Title The changes in vaginal flora by intake of lactobacillus.
Date of disclosure of the study information 2017/01/20
Last modified on 2021/07/26 11:29:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The changes in vaginal flora by intake of lactobacillus.

Acronym

The changes in vaginal flora by intake of lactobacillus.

Scientific Title

The changes in vaginal flora by intake of lactobacillus.

Scientific Title:Acronym

The changes in vaginal flora by intake of lactobacillus.

Region

Japan


Condition

Condition

menopause

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Taking the test beverage for 4 weeks and we evaluate the occupation rate of Lactobacillus in the vagina before and after intaking.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Taking the test beverage for 4 weeks and we evaluate the occupation rate of Lactobacillus in the vagina before and after intaking.

Key secondary outcomes

Taking the test beverage for 4 weeks and we evaluate the occupation rate of Lactobacillus Bifidobacterium around the anus before and after intaking.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

The subjects take lactobacillus beverage for 4 weeks.The placebo group take control beverages for 4 weeks.

Interventions/Control_2

The subjects take 200 ml per day both lactic acid bacteria beverage and control beverage. Lactobacillus beverage contains 100 mg of Lactobacillus gasseri OLL 2809.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <

Age-upper limit

70 years-old >

Gender

Female

Key inclusion criteria

Postmenopausal women

Key exclusion criteria

Persons who have serious complications.
Those who judge that the research doctor is inappropriate.
Persons who are allergic to milk.
Those who participated in other trials or clinical trials within one month.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Kazuhiro
Middle name
Last name Sugihara

Organization

Hamamatsu University School of Medicine

Division name

Obstetrics and Gynecology

Zip code

431-3192

Address

Handayama 1-20-1 Higasi-ku Hamamatsu city Shizuoka prefecture

TEL

053-435-2309

Email

sugihara@hama-med.ac.jp


Public contact

Name of contact person

1st name Masashi
Middle name
Last name Adachi

Organization

Hamamatsu University School of Medicine

Division name

Obstetrics and Gynecology

Zip code

431-3192

Address

Handayama 1-20-1 Higasi-ku Hamamatsu city Shizuoka prefecture

TEL

053-435-2309

Homepage URL


Email

adachi@hama-med.ac.jp


Sponsor or person

Institute

Hamamatsu University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Meiji

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research Ethics Committee

Address

1-20-1, Handayama, Higashi, Hamamatsu City, Shizuoka Prefecture

Tel

053-435-1111

Email

rinri@hama-med.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

2016-022

Org. issuing International ID_1

Meiji Ethics Review Committee

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

浜松医科大学附属病院


Other administrative information

Date of disclosure of the study information

2017 Year 01 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2017 Year 01 Month 05 Day

Date of IRB

2016 Year 12 Month 15 Day

Anticipated trial start date

2017 Year 01 Month 05 Day

Last follow-up date

2019 Year 01 Month 04 Day

Date of closure to data entry

2019 Year 01 Month 04 Day

Date trial data considered complete

2019 Year 01 Month 04 Day

Date analysis concluded

2019 Year 01 Month 04 Day


Other

Other related information



Management information

Registered date

2017 Year 01 Month 19 Day

Last modified on

2021 Year 07 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029588


Research Plan
Registered date File name
2021/07/26 (4)研究計計画.改.doc

Research case data specifications
Registered date File name

Research case data
Registered date File name